Bristol-Myers Squibb Company
Net Cash Flow Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
FY2009
FY2008
FY2007
Total Cash from Operations: $10.51B
| Line Item | Value | % of Total |
|---|---|---|
| Dividends Paid | $1.52B | 14.5% |
| Net Change in Short-Term Borrowings | $1.05B | 9.9% |
| Working Capital | $1.72B | 16.4% |
| Other | $42.0M | 0.4% |
| Net Cash Flow | $6.18B | 58.8% |